At 12:45 CEST on 26 August at ESC 2023, Radcliffe Medical Education is hosting a CME-accredited symposium entitled 'The Advancing Management of Transthyretin Amyloidosis: A practical guide'. Mark your calendar and join us in the Lisbon Room. 
 

Join Prof Julian Gillmore (University College London, London, UK) as he chairs a panel of distinguished experts, Dr Martha Grogan (Mayo Clinic College of Medicine, US), Dr Laura Obici (I.R.C.C.S. San Matteo Polyclinic, IT) and Prof Arnt Kristen (University of Heidelberg, Heidelberg, DE) in this interactive symposium covering the unique challenges of ATTR in diagnosis, assessment, long-term management and future treatment options.  

Have your questions answered as the faculty explore guidelines, trial data and provide expert-opinion through interactive video case study and audience participation. 

The Advancing Management of Transthyretin Amyloidosis: A Practical Guide’s programme has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC) for 1 CME point, equating to 1 hours of learning. Physicians may convert EBAC External CME credits to AMA PRA Category 1 Credits™.

Learning Objectives

• To differentiate ATTR phenotypes based on presenting signs and symptoms.
   
• To select appropriate tests to monitor symptomatic ATTR-cm from imaging, biomarker, functional and QoL assessments.
   
• To recall how to identify disease progression across ATTR-cm.
   
• To describe the different disease modifying treatments for ATTR including novel agents.

 The Advancing Management of Transthyretin Amyloidosis – Programme 

• Session 1: ATTR – a multi-system disease posing unique challenges
   
• Session 2: Assessing cardiac manifestations of ATTR
   
• Session 3: Long-term management
   
• Session 4: What’s in our future toolbox?
   
• Session 5: Meeting summary and conclusions

This Satellite Symposium is supported by an unrestricted educational grant from AstraZeneca who has no involvement in the content.